Login

Healthcare

00:00:00
NetScientific PLC actively driving its investee companies forward - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific
00:00:00
NetScientific PLC present at the Proactive One2One Investor Forum - January 26th 2023 - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific
00:00:00
NetScientific PLC discusses FDA fast-track of its portfolio company's cancer treatment - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific
00:00:00
ASX Small & Mid Cap Conference: Neuren Pharmaceuticals Limited - Jon Pilcher, BSc (Hons), FCA Chief Executive Officer/Managing Director, Neuren Pharmaceuticals Ltd
00:00:00
Biotech Unlocked - NEUREN PHARMACEUTICALS - ASX:NEU - Jon Pilcher, BSc (Hons), FCA Chief Executive Officer/Managing Director, Neuren Pharmaceuticals Ltd
00:00:00
Neuren Pharmaceuticals CEO Jon Pilcher discusses on Phase 3 LAVENDER Rett Syndrome trial. - Jon Pilcher, BSc (Hons), FCA Chief Executive Officer/Managing Director, Neuren Pharmaceuticals Ltd
00:00:00
Erik Kinnman, CEO, NeuroVive Pharmaceutical
00:00:00
Catherine Turkel Discusses Pharmacy School and Novus Therapeutics - Catherine Turkel, President, Novus Therapeutics Inc
00:00:00
Noxopharm CEO talks Veyonda orphan drug designation from US FDA - Dr Gisela Mautner Chief Executive Officer and Managing Director, Noxopharm Ltd
00:00:00
Noxopharm details science-driven strategy in new investor presentation - Dr Gisela Mautner Chief Executive Officer and Managing Director, Noxopharm Ltd
00:00:00
Noxopharm hails new Sofra™ drug inflammation results - Dr Gisela Mautner Chief Executive Officer and Managing Director, Noxopharm Ltd
00:00:00
Noxxon CEO discusses partners and cancer combinations - Aram Mangasarian , CEO, NOXXON Pharma
00:00:00
Aram Mangasarian , CEO, NOXXON Pharma
00:00:00
Interview with Aram Mangasarian, CEO of NOXXON
00:00:00
Aram Mangasarian , CEO, NOXXON Pharma
00:00:00
Francois Martelet, CEO, Oasmia Pharmaceutical

© 2017 - Townhall + Tv